{
  "ticker": "CLDX",
  "company_name": "Celldex Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05484011",
      "title": "A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Metastatic Pancreatic Adenocarcinoma",
      "start_date": "2022-12-15",
      "completion_date": "2024-03-04",
      "enrollment": 0,
      "sponsor": "HiberCell, Inc."
    },
    {
      "nct_id": "NCT02270372",
      "title": "Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Advanced Breast Carcinoma, Advanced Ovarian Carcinoma",
      "start_date": "2014-11",
      "completion_date": "2016-06",
      "enrollment": 0,
      "sponsor": "Cascadian Therapeutics Inc."
    },
    {
      "nct_id": "NCT03835533",
      "title": "Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Metastatic Castration-resistant Prostate Cancer",
      "start_date": "2019-06-21",
      "completion_date": "2022-10-03",
      "enrollment": 0,
      "sponsor": "Parker Institute for Cancer Immunotherapy"
    },
    {
      "nct_id": "NCT02543645",
      "title": "A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Neoplasms by Histologic Type, Neoplasms, Clear-cell Metastatic Renal Cell Carcinoma, Melanoma, Triple Negative Breast Cancer, Bladder Cancer, Head and Neck Cancer, Non-small Cell Lung Cancer",
      "start_date": "2015-10",
      "completion_date": "2017-05-22",
      "enrollment": 0,
      "sponsor": "Celldex Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 4,
    "by_phase": {
      "PHASE1": 4
    },
    "by_status": {
      "TERMINATED": 2,
      "COMPLETED": 2
    },
    "active_trials": 0,
    "completed_trials": 2,
    "conditions": [
      "Advanced Breast Carcinoma, Advanced Ovarian Carcinoma",
      "Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Neoplasms by Histologic Type, Neoplasms, Clear-cell Metastatic Renal Cell Carcinoma, Melanoma, Triple Negative Breast Cancer, Bladder Cancer, Head and Neck Cancer, Non-small Cell Lung Cancer",
      "Metastatic Castration-resistant Prostate Cancer",
      "Metastatic Pancreatic Adenocarcinoma"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:43:58.848816",
    "search_query": "Celldex Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Celldex+Therapeutics,+Inc."
  }
}